Braizon Therapeutics, Inc. is working to solve the blood brain barrier problem for oligonucleotide therapeutics, removing the need for spinal cord injections to treat neurological disorders. Our Brain Access platform utilizes novel IP combining polymer nanoparticles with proven targeting methods for targeting therapies to the brain to create IV formulations for our partners. This platform is under development for expansion into small molecule, peptide, and antibody drug delivery into the brain. HQ'd in Tokyo, Braizon has US operations in Cambridge, MA. enabling our experienced team to offer partnering worldwide for biotech and Pharma with a strategic focus on neurology.
View Top Employees from Braizon Therapeutics, Inc.| Website | https://braizon.com/en/ |
| Revenue | $3 million |
| Employees | 6 (5 on RocketReach) |
| Founded | 2015 |
| Phone | +81 3-5805-3417 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Drug Delivery, Manufacturing, Science and Engineering, Education, Medical, Health Care |
| SIC | SIC Code 873 Companies, SIC Code 20 Companies, SIC Code 87 Companies, SIC Code 21 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 33 Companies, NAICS Code 312 Companies, NAICS Code 31 Companies, NAICS Code 3122 Companies |
Looking for a particular Braizon Therapeutics, Inc. employee's phone or email?
Braizon Therapeutics, Inc. Questions
The Braizon Therapeutics, Inc. annual revenue was $3 million in 2024.
Mariko Tosu is the Founder and Chairperson of Braizon Therapeutics, Inc..
5 people are employed at Braizon Therapeutics, Inc..
Braizon Therapeutics, Inc. is based in Tokyo, Tokyo.
The NAICS codes for Braizon Therapeutics, Inc. are [541, 54, 33, 312, 31, 3122].
The SIC codes for Braizon Therapeutics, Inc. are [873, 20, 87, 21].
Top Braizon Therapeutics, Inc. Employees
Related Companies
